首页> 外文期刊>AJNR. American journal of neuroradiology >Changes in Aqueductal CSF Stroke Volume and Progression of Symptoms in Patients With Unshunted Idiopathic Normal Pressure Hydrocephalus.
【24h】

Changes in Aqueductal CSF Stroke Volume and Progression of Symptoms in Patients With Unshunted Idiopathic Normal Pressure Hydrocephalus.

机译:未分流的特发性常压性脑积水患者的脑脊液中风量变化和症状进展。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND AND PURPOSE: Idiopathic normal pressure hydrocephalus (iNPH) represents a diagnostic challenge, given its variable presentation and progression. Stroke volume (SV), defined as the mean volume of CSF passing through the aqueduct during both systole and diastole, greater than or equal to 42 muL, serves as a selection criterion for patients with good probabilities of improvement after ventriculoperitoneal shunt surgery (VPS). In this study, we evaluated the changes in SV during the progression of clinical symptoms in patients with suspected NPH. MATERIALS AND METHODS: Nine patients who presented with clinical and radiologic evidence of NPH, but refused treatment with VPS, were evaluated every 6 months for up to 2 years for progression in their clinical symptoms and changes in their SV, as measured by phase-contrast cine MR imaging (PCCMR). RESULTS: SV seems to increase between the onset of the symptoms and the following 18 to 20 months, then seems to plateau, followed in the next 18 to 20 months by a slight decline, and finally to a more precipitous drop in the next 12 months. During this time, however, the patient's clinical symptoms progressively worsen. CONCLUSION: Patients with a low SV have not necessarily had brain atrophy and can show, in the following months, a progressive increase in SV, which qualifies them as good candidates for VPS. The progressive reduction of the SV in untreated patients with worsening clinical symptoms may be a sign of a progressive cerebral ischemic injury, which renders the NPH irreversible.
机译:背景和目的:特发性常压性脑积水(iNPH)代表了诊断挑战,因为其可变的表现形式和进展。脑卒中体积(SV)定义为在收缩期和舒张期通过水管的CSF的平均体积,大于或等于42μL,可作为心室腹膜分流手术(VPS)后有良好改善可能性的患者的选择标准。在这项研究中,我们评估了疑似NPH患者在临床症状进展期间SV的变化。材料与方法:9例表现出NPH的临床和影像学证据但拒绝接受VPS治疗的患者,每6个月进行一次长达2年的评估,评估其临床症状进展和SV变化(以相差法测量)电影MR成像(PCCMR)。结果:在症状发作至随后的18到20个月之间,SV似乎升高,然后趋于平稳,在接下来的18到20个月中略有下降,最后在接下来的12个月中急剧下降。然而,在此期间,患者的临床症状逐渐恶化。结论:SV低的患者不一定患有脑萎缩,并且在接下来的几个月中可能会显示SV逐渐增加,这使他们有资格成为VPS的良好候选人。在未经治疗的临床症状恶化的患者中,SV的逐渐降低可能是进行性脑缺血损伤的信号,这使NPH不可逆。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号